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Abstract 
A thorough understanding of the diseased tissue state is necessary for the successful 
treatment of a blocked arterial vessel using stent angioplasty. The constitutive representation 
of atherosclerotic tissue is of great interest to researchers and engineers using computational 
models to analyse stents, as it is this in silico environment that allows extensive exploration 
of tissue response to device implantation. This paper presents an in silico evaluation of the 
effects of variation of atherosclerotic tissue constitutive representation on tissue mechanical 
response during stent implantation. The motivation behind this work is to investigate the level 
of detail that is required when modelling atherosclerotic tissue in a stenting simulation, and to 
give recommendations to the FDA for their guideline document on coronary stent evaluation, 
and specifically the current requirements for computational stress analyses. This paper 
explores the effects of variation of the material model for the atherosclerotic tissue matrix, 
the effects of inclusion of calcifications and a lipid pool, and finally the effects of inclusion of 
the Mullins effect in the atherosclerotic tissue matrix, on tissue response in stenting 
simulations. Results indicate that the inclusion of the Mullins effect in a direct stenting 
simulation does not have a significant effect on the deformed shape of the tissue or the stress 
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state of the tissue. The inclusion of a lipid pool induces a local redistribution of lesion 
deformation for a soft surrounding matrix and the inclusion of a small volume of 
calcifications dramatically alters the local results for a soft surrounding matrix. One of the 
key findings from this work is that the underlying constitutive model (elasticity model) used 
for the atherosclerotic tissue is the dominant feature of the tissue representation in predicting 
tissue response in a stenting simulation. 
Introduction 
Atherosclerotic tissue is highly heterogeneous and can be comprised of a lipid core, 
calcifications, cellular debris, and fibrous tissue. However, the representation of 
atherosclerotic plaque tissue in computational stenting simulations has predominantly been as 
a homogeneous continuum, for example as presented in [1–8] and as most recently reviewed 
in [9]. Even though the analysis of angioplasty with stenting has been an area of intense 
interest to the computational biomechanics community in recent years [10], stenting 
simulations where the heterogeneous nature of the atherosclerotic tissue is explicitly 
represented are rare [10]. One study of note is that of Timmins et al. [8] where the stiffness of 
the plaque wall was varied with respect to the arterial stiffness. In addition to this work there 
has a small number of studies that do explicitly represent plaque substructure includes the 
work of Holzapfel et al. [11] where distinct lipid and calcified regions are represented in a 
patient specific model of coronary stent angioplasty; the work of García et al. [12] where 
models to assess self-expanding stent radial force are generated with lipid or calcified plaque 
cores; the work of Iannaccone et al. [10] where models with lipid pools and fibrous caps are 
generated to assess the effect of vascular anatomy on carotid stenting; and the work of 
Morlacchi et al. [13] where an assessment is made of the influence of large plaque 
calcifications on coronary stent fatigue life. Computational approaches to plaque modelling 
relevant to this application have recently been reviewed in Holzapfel et al. [14]. 
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In conjunction with geometrical simplifications, the behaviour of atherosclerotic plaque 
tissue is generally considered to be hyperelastic and that it follows physiological behaviour 
(domain where blood pressure in arterial walls is less than 140 mmHg [15]), despite the fact 
that loading due to stent placement introduces supra-physiological forces (pressures above 
the physiological blood pressure) within the tissue.  
This simplicity in constitutive representation is based on the fact that, relative to non-diseased 
(healthy) arterial tissue, and other widely studied bodily tissues such as bone for example, 
there is a distinct lack of comprehensive experimental data for the properties of 
atherosclerotic plaque tissue [16,17]. This lack of data can be due, amongst other factors, to 
the difficulty in obtaining, isolating and handing the tissue, the inherent variability and 
heterogeneity of the tissue, and the lack of a robust animal model that is representative of the 
disease in humans.  
Where mechanical characterisation of atherosclerotic tissue has been addressed, the most 
common approach has been to view the tissue from a macroscopic continuum mechanics 
perspective, where the focus has not been on the mechanical characterisation of local plaque 
constituents, for example as presented in [18–25].  
A smaller group of studies has focused on plaque tissue substructure mechanical 
characterisation, using a range of testing techniques. This includes the work of Holzapfel et 
al. [26] on plaque tissue component tensile testing; Lee et al. [27] who tested atherosclerotic 
plaque caps in cyclic compression; Loree et al. [28] who investigated the shear modulii of 
synthetic lipid pools; Ebenstein et al. [29] who used nano-indentation to investigate the 
mechanical properties of individual constituents; and Barrett et al. [30] and Chai et al. [31] 
who used micro-indentation to mechanically characterise atherosclerotic carotid plaque caps 
[31,32], and carotid intima and lipid cores [31]. Nano- and micro-indentation, while 
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presenting great potential for spatially resolving local tissue variations, are limited in the 
strain ranges that can be applied, which render them of limited use for characterising tissue 
behaviour in the high-strain supra-physiological domain relevant to the stenting application. 
In this context, data for mechanical (tensile) testing to rupture is particularly valuable [33]. 
More recently, Mulvihill et al. [34] reported tensile test data for non-calcified and calcified 
human carotid plaque tissue. For further information on atherosclerotic tissue testing, 
characterisation and relevant material properties, the reader is referred to the recent 
comprehensive review [16] and a “plaque mechanics” special issue [17] (in particular 
[14,33,35–37]).   
Against this backdrop of limited experimental data, the primary aim of this work is to 
investigate the level of detail that is necessary and appropriate when modelling the response 
of atherosclerotic plaque tissue to stenting. It is hoped that the results will inform the choice 
and design of experiments necessary to adequately characterise the tissue for use in 
computational models. It will be confirmed (consistent with the observations above) that not 
only is further experimentation on atherosclerotic tissue required but also that knowledge of 
the tissue behaviour in failure is vital. An additional motivation for the present work is to 
provide recommendations to the FDA for the stress-strain analysis section of their guideline 
document on non-clinical engineering tests for coronary stents [38] for modelling the 
physiological environment.  
Specifically, a 50% stenosed three layer arterial model is used as a basis for the analyses, 
which forms part of the computational test bed developed and presented in Conway et al. [1]. 
Atherosclerotic tissue is varied from being a homogenous continuum to having a lipid rich 
core, to also having diffuse calcifications throughout. Several material models are also 
investigated as the base atherosclerotic tissue matrix in the analyses. This includes applying 
different elastic models to describe the physiological response and then including damage 
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models which account for the response of the tissue to supra-physiological loading. Using 
this artery model within the computational test bed, analysis focuses on the deployment of a 
generic stent geometry using balloon expansion. The response of the system is assessed in 
terms of tissue deformation and stress state.  
Materials & Methods 
Geometry & Meshes 
The commercially available Abaqus/Explicit solver (DS SIMULIA, USA) is used for all 
computational modelling performed in this work. For the analyses, a 50% stenosed three 
layer arterial model geometry, labelled SAL50, (abbreviated from Straight Artery with 
Lesion of 50%, illustrated in Figure 1, see also Conway et al. [1]) is used. This geometry 
consists of a 0.5 mm thick non-diseased arterial wall equally divided into three layers 
representing the intima, media and adventitia. The stenosis is considered semi-ellipsoidal in 
shape and blocks 50% of the available lumen by area, at the maximum axial cross-section. 
Each section was meshed with 3D eight noded reduced integration linear continuum 
hexahedral elements. The final mesh for the SAL50 geometry consists of 130064 elements, 
arrived at after a sensitivity study with the convergence criterion that the maximum von 
Mises stresses, at specific spatial locations, converge within 5%. A thin outer layer of four 
noded linear reduced integration shell elements, is also included in the arterial model to 
represent the physiological environment in which an artery would be embedded. 
To examine the response of inhomogeneous atherosclerotic tissue to stenting, two further 
modifications are included in the SAL50 model. The first is the inclusion of a lipid pool 
section as shown in Figure 1 and the second is the inclusion of diffuse calcified particles as 
shown in Figure 2. The volume of lipid included represents 9.3% of the total atherosclerotic 
tissue volume. The calcified particles are randomly distributed in the atherosclerotic bulk; 
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630 calcified particles are used, representing 0.5% of the total atherosclerotic tissue volume 
and the volume of a single particle is approximately 0.0002 mm
3
, determined from 
observation of histological sections of diseased tissue in Stary[39].  To allow assignment of 
the calcified regions the element size had to be reduced to represent an individual calcified 
particle, resulting in a mesh size increase to 726958 elements. The resulting mesh density was 
deemed acceptable while still allowing solutions to be generated in a reasonable time frame; 
typical simulation times are quoted in below in the Analysis of Results section. 
A generic stent geometry is used in this study that is representative of the Cypher closed-cell 
stent, as used previously in Conway et al.[1].  The mesh generated consists of 30000 eight 
noded reduced integration linear continuum hexahedral elements. This was compared with 
published mesh densities [40,41] for similar stent designs and was deemed acceptable based 
on these comparisons. The balloon catheter and guidewire delivery system are based on 
designs presented in the work of Mortier et al. [41]. The guidewire has a diameter of 0.2 mm 
and the catheter is modelled with a diameter of 0.22 mm. The balloon in its unwrapped 
configuration reaches a diameter of 3 mm. The wrapping of the balloon is simulated by the 
method outlined in Laroche et al. [42], and explained in Conway et al.[1]. 
Constitutive Models 
Each layer of the non-diseased arterial wall is considered incompressible and anisotropic and 
the model proposed by Gasser et al.[43] is applied. This model and the values for the material 
constants are fully described in Conway et al.[1] and for brevity are not repeated here. The 
thin outer layer of shell elements is considered to be isotropic and to be linear elastic in terms 
of finite deformation strain and stress measures. It has a Young's Modulus of E = 50 kPa and 
a Poisson's Ratio of υ = 0.3, and has a thickness of 0.1 mm. A similar approach was applied 
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by Harewood et al. [44] so that physiologically representative boundary conditions could be 
applied to the artery. 
For the atherosclerotic tissue several material models are investigated. The first approach 
utilises the second order polynomial incompressible hyperelastic form published by Pericevic 
et al. [2] (full details given in [1] and not repeated here for brevity) referred to in the present 
paper as the P2 model. The P2 model is based on the tensile testing response of 
atherosclerotic tissue carried out by Loree et al. [18]. The second approach utilises the data 
published by Maher et al. [23], which resulted from the testing of atherosclerotic tissue in 
compression. A first order incompressible Ogden model (Ogden N1 – with ‘N’ representing 
the number of terms in the model) (Ogden model framework detailed in [45], and not 
repeated here for brevity) was fitted to this compressive test data. The third approach 
combined the Loree tensile data [18] with the Maher compressive data [23] to fit a sixth order 
incompressible Ogden model (Ogden N6) describing the response of the tissue in tension and 
compression (once again, detailed in [45], and not repeated here for brevity). Figure 3 shows 
the uniaxial responses of the three models in tension and compression. As can be seen from 
the figure, the behaviour of the Ogden N6 model is significantly stiffer in tension than 
compression, reflexive of the respective experimental data sets ([46] vs. [47]). This difference 
in experimental tension vs. compression behaviour has also been noted and discussed in 
Alyilidiz et al. [35], where it has been attributed to the presence of collagen fibres in the 
plaque tissue which participate to a much greater extent in load carrying in tension relative to 
compression. Having said this however it must also be realised that there is significant 
variability in reported tissue mechanical properties, as is well acknowledged [33,35,36], 
making it difficult to definitively generalise on relative tensile and compressive stiffnesses. 
The three approaches described only give the response of the tissue to physiological loading. 
To account for supra-physiological loading due to stent implantation, the elasticity models for 
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the atherosclerotic tissue are combined with different damage modelling approaches. The P2 
model is combined with a perfect plasticity model, as per the approach of Gastaldi et al. [3], 
and as used in Conway et al. [1], to limit the stresses supported by the atherosclerotic tissue, 
and a yield stress of 0.4 MPa is assumed. The compressive data published by Maher et al. 
[23] gave the cyclic response of the tissue to loading. In that paper the authors fitted their 
own damage model to capture the stress softening and permanent set observed within the 
tissue during loading. Here, using the cyclic response data [23] the Abaqus Mullins effect 
model is calibrated to the Maher data and combined with the Ogden N1 model. The Mullins 
effect model within Abaqus is an implementation of the Ogden and Roxburg [48] 
discontinuous damage model that is characterised by stress softening of an elastic material 
upon unloading; for details see references [45,48]. A similar procedure is carried out for the 
Ogden N6 model. The response of the Ogden models incorporating the Mullins effect to 
strain controlled cyclic loading is illustrated graphically in Figure 4. The response of the P2 
model with perfect plasticity to monotonic loading is also shown. 
The calcifications are considered to be isotropic and to be linear elastic in terms of finite 
deformation strain and stress measures. They have a Young's Modulus of E = 1 GPa and a 
Poisson's Ratio of υ = 0.3. The stiffness of the particles is taken from the experimental data of 
Ebenstein et al. [29]. The lipid pool is considered to be isotropic, to behave as a very soft 
incompressible solid and is modelled using the isotropic part of the Gasser et al. [43] material 
model, which reduces to a Neo-Hookean representation, with a material constant of 0.05 kPa.  
The elastic behaviour of the stent  is considered to be linear and isotropic in terms of finite 
deformation stress and strain measures, with a Young’s Modulus of E = 200 GPa and 
Poisson’s Ratio of υ = 0.28 (representative of biomedical grade stainless steel alloy 316L). 
Plasticity is described by isotropic hardening J2 flow theory, where the specific form of the 
strain hardening curve is taken from McGarry et al. [49], including a yield strength of 264 
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MPa and an ultimate tensile strength (UTS) of 584 MPa at an engineering plastic strain of 
0.247. This methodology is consistent with the general approach taken in the literature for 
stent deformation, for examples see [50–52]. 
In the stent deployment assembly, a semi-compliant nylon balloon mounted on a high density 
polyethylene catheter positioned using a nitinol guidewire is used. Each are modelled as 
behaving as linear and isotropic in terms of finite deformation stress and strain measures, 
similar to the approach documented in Mortier et al. [41]. The guidewire deformations are 
assumed to be small and superelastic properties of nitinol are neglected. The values for the 
elastic constants for each component are given in Table 1, included also is the mass 
proportional Rayleigh damping coefficient, α, used for each component in the delivery 
system. For the balloon in particular, this means that unrealistic diameter fluctuations during 
the inflating and unfolding of the balloon are avoided through energy dissipation. 
Boundary Conditions & Loading 
To allow application of appropriate boundary conditions to the arterial segments, a 10 mm 
length of straight three layer arterial mesh is added to both ends of each arterial segment, as 
described previously in Conway et al. [1]. The proximal and distal extremities of the 
extended arterial model are then constrained in all directions. This is to allow for more 
representative arterial behaviour during the balloon inflation and deflation. The proximal and 
distal ends of the layer of shell elements surrounding the arterial vessel are also pinned. The 
inclusion of this layer of elements adds more stability to the analyses as this material is 
assigned a mass proportional Rayleigh damping coefficient similar to that used for the 
balloon-catheter assembly components. A coefficient of friction of 0.2 is applied to all 
contacting surfaces during deployment analyses, as per the approach of Mortier et al. [41]. As 
described previously in Conway et al. [1], the pressure applied to the inner surface of the 
folded balloon is 1.1 MPa which was determined from a free expansion simulation.  
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Analysis of Results 
The first quantity of interest in the simulations performed is the deformed lumen shape. To 
examine this, a python script was generated which calculates the lumen cross-sectional area 
based on the deformed nodal coordinates in the Abaqus output data for a sequence of 
circumferential paths along the length of the lesion. For each material model investigated the 
lumen cross-sectional area along the length of the atherosclerotic tissue is plotted. To 
compare each model macroscopically, an average lumen cross-sectional area is calculated 
and compared with the reference lumen area. All the above are evaluated at two time points 
for each model, at maximum balloon inflation and post balloon deflation. 
The second quantity of interest is the stress state in the non-diseased arterial wall. The 
variation of the constitutive behaviour of the atherosclerotic tissue has an effect on the 
stresses transferred to the non-diseased arterial wall. The percent tissue damage risk (as 
defined in Conway et al. [1]) is calculated in each non-diseased arterial layer for each 
variation in constitutive model. This value determines the proportion of elements with von 
Mises stresses exceeding reported UTS values for each arterial layer compared to the total 
number of elements [1]. 
 
Finally, the third quantity of interest is the stress state in the diseased atherosclerotic tissue 
and for this several sets of stress contour plots were examined at two time points, maximum 
balloon inflation and post deflation. 
Run times for these analyses were on the order of 400 CPU hours each on a SGI Altix ICE 
8200EX cluster, and the run time more than doubled when the mesh density was increased to 
include calcifications in the analyses.  
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Results 
Deformed Lumen Measurements 
The first atherosclerotic tissue model to be examined in terms of deformed lumen 
measurements is the Ogden N1 model. Figure 5 - B, D show the results for the cross-sectional 
area along the length of the lesion for the Ogden N1 model (OgN1), with and without 
inclusion of the Mullins effect and the lipid pool. Two time points are examined, maximum 
balloon inflation and post balloon deflation. Clearly apparent in Figure 5 are the many 
“jagged” regions along the deformed lumen lines. This is indicative of the general 
compliance of the lesion material that is allowing localised indentation around the stent struts. 
The first point to note is that the behaviour at the two time points is different due to vessel 
recoil, and this is manifested in terms of two distinct “tiers” in Figure 5. The Mullins effect is 
only formally activated on unloading and in the top tier the curves show that the lumen 
deformations, with and without Mullins, are in agreement at maximum inflation, within the 
bounds of numerical accuracy for models of such complexity.  Note that the lipid pool has 
only a minimal effect at maximum inflation. 
Even though the Mullins effect is active on unloading, consideration of the bottom tier of 
results in Figure 5 for deflation shows that inclusion of the Mullins effect has little influence 
on the response of the Ogden N1 model. On the other hand, the inclusion of a lipid pool does 
generate a noticeable effect, most significantly in terms of a redistribution of the lesion 
deformation along the length of the lesion, in particular local to the stent struts, emphasised 
by the deformed plot states in Figure 7- C, D. 
Figure 5 - G shows the results for the inclusion of diffuse calcifications in conjunction with 
the Ogden N1 (OgN1) model, with and without the Mullins effect. One observes a significant 
difference when calcifications are included, if Figure 5 – B, D and Figure 5 - G are compared. 
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The calcifications not only affect the unloaded configuration and the distribution of lesion 
deformation along the length of the lesion but also the maximum cross-sectional area 
achieved by the stented lumen. In general the presence of calcifications appears to lower the 
lumen cross-sectional area.  
Figure 5 – A, D show the results for the cross-sectional area along the length of the lesion for 
the Ogden N6 model (OgN6), with and without inclusion of the Mullins effect and the lipid 
pool. The results at maximum balloon inflation are very similar, as for the Ogden N1 case. 
However in contrast to the Ogden N1 case, on unloading the results remain quite similar; 
again, the inclusion of the Mullins effect produces little difference on the luminal measures, 
but additionally, this time, the analyses appear to be not that sensitive to the presence of a 
lipid pool.  
The next case to be examined is that for the P2 model for the lesion, again at two time points, 
inflation and deflation, with and without plasticity and with and without a lipid pool present. 
Figure 5 – C, F show the results for lumen cross sectional area along the length of the lesion. 
To remind the reader, the P2 model is much stiffer in tension and in compression than the 
Ogden N1 model (as shown in Figure 3) so the lumen deformations are much smoother 
around the stent struts due to this increase in stiffness. Secondly there is significant difference 
at maximum balloon inflation between the pure hyperelastic polynomial and hyperelastic in 
combination with plasticity.  There is more lumen gain when the plasticity model is used, as 
due to its characteristics the stress is limited, which encourages straining within the tissue.  
The difference between the respective curves on deflation of the balloon is also significant. 
The difference between the curves with plasticity is less than the difference between the pure 
hyperelastic curves. This indicates that vessel recoil is less on inclusion of plasticity (an 
effect noted in the authors’ previous work [1]). Finally, the inclusion of a lipid pool in this set 
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of analyses tends to increase the lumen gain in the middle region of the lesion in all cases. 
This is most likely due to a softening effect on its inclusion, relative to the stiffness of the P2 
material, which means it is easier to deform the tissue. However, the effect is much less than 
the effect of plasticity on its own. 
Figure 6 shows the results for the percentage difference in the average lumen area compared 
with the reference lumen area, at maximum balloon inflation and post balloon deflation, for 
all models discussed above. A value of zero on this graph indicates that the overall average 
cross-sectional area is the same as the required reference lumen area, i.e. no net difference 
between the overall deformed cross-sectional area and the reference lumen area. A positive 
value on this graph indicates that the average cross-sectional area is greater than the reference 
lumen area and conversely a negative value indicates that the average lumen cross-sectional 
area is less than the reference lumen area. From Figure 6 it can be observed that this quantity, 
due to its macroscopic nature, is probably the least sensitive to model changes of the 
measures considered here. At maximum balloon inflation the percent change varies only 
between 7 to 11 percent for all material models. Differences post balloon deflation are more 
significant, where the percent change varies between -5 to 4.5 percent for all material models. 
Differences are negative, i.e. less than the reference lumen area (least lumen gain), when 
calcifications are included and when the polynomial model is used. Also to note in the case of 
negative differences, is that the stent expanded the vessel relative to the diseased state but did 
not reach the unstenosed vessel area. In these cases the stent design is being more challenged 
in its scaffolding ability due to the stiffness of the lesion material. From Figure 6 the 
inclusion of calcifications does have a noticeable overall effect of stiffening the lesion 
material, while inclusion of plasticity has a substantial softening effect on the P2 response; 
the effect of the lipid pool is much less significant, for all of the base elasticity models used. 
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Overall, the results shown in Figure 5 and Figure 6, suggest that the stiffness of the base 
elasticity model may be the most important parameter in determining the luminal measures 
considered here. The lipid pool does appear to have an effect locally in the lesion, which is 
dependent on the base elasticity model, but not significantly in terms of the overall average 
behaviour. The calcifications and the plasticity each have noticeable effects, both locally and 
on average. However, the inclusion of the Mullins effect does not appear to be that important, 
at least for the range of base elasticity models for the lesion considered here.  
Tissue Damage Risk  
Next the stress state in the non-diseased arterial wall at two time points, maximum balloon 
inflation and post balloon deflation is examined. Table 2 shows the predicted percent tissue 
damage risk results in each arterial layer, for all atherosclerotic tissue models previously 
discussed, in the SAL50 model, with a homogenous lesion representation and with a lesion 
with a lipid pool and with a lesion with calcifications.  
In the first case, of a homogenous lesion, as expected, the predominant percent tissue damage 
risk occurs in the innermost layer, the intima, with substantially less damage likely in the 
outer two layers. The stiffer lesion as represented by the P2 model seems to inflict the 
greatest damage in all three layers. The least stiff model, Ogden N1, results in less damage to 
the intimal layer and negligible damage to the other two layers by comparison. In all cases, 
the results indicate that damage is greater at maximum balloon inflation, as would be 
expected. For this particular performance measure, the Mullins effect has only a very minor 
influence. Relative to this the inclusion of plasticity with the P2 model has a somewhat 
greater influence, in particular for the medial and adventitia layers.  
The effect of including a lipid pool is shown in the percent tissue damage risk results in  the 
second case of Table 2 for all six types of atherosclerotic lesion modelled. A very similar 
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trend can be observed when compared with the previous case but on the whole the percent 
tissue damage risk is slightly less in all cases. This suggests an overall slight softening effect 
due to the presence of the lipid pool, which is consistent with the general trend observed for 
the luminal cross-sectional area results.  
Finally, the effects of including calcifications in the base atherosclerotic matrix, on the 
percent tissue damage risk are compared in the third case of Table 2. The base atherosclerotic 
matrix is modelled using the Ogden N1 model and results are shown with and without the 
Mullins effect. The inclusion of a small percentage of calcifications results in stiffening and 
an increase in percent tissue damage risk, and this even becomes apparent in the medial layer.  
Stress Distribution in Atherosclerotic Tissue 
The reader is referred to Figure 7 for examples of the stress state in the deformed 
atherosclerotic tissue modelled with Ogden N1, at maximum balloon inflation and post 
balloon deflation, with and without the lipid pool and calcifications. The first point to note is 
the overall differences in stress level between the respective plots in the two columns in  
At maximum balloon inflation (left column – Figure 7- A,C,E) the atherosclerotic tissue is 
more highly stressed than after balloon deflation (right column –Figure 7 - B,D,F). This is to 
be expected as after the balloon is deflated it is only the stent that is exerting a load on the 
artery, as the vessel attempts to return to its original stress state. The inclusion of a lipid pool 
lowers the overall stress in the atherosclerotic tissue whereas the inclusion of calcified 
particles increases the overall stress in the tissue. Interestingly, when calcifications are 
present the von Mises stress in the non-calcified tissue is increased around the stent struts.  
The von Mises stress is, however, is a positive scalar quantity that gives a good indication of 
the multi-axial stress state magnitude but does not capture whether the material is in tension 
or compression. For this reason, the maximum and minimum principal stresses at maximum 
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balloon inflation are also examined. In Figure 8 the minimum and maximum principal 
stresses in atherosclerotic tissue modelled with Ogden N1, with and without the lipid pool 
and calcifications are shown. From the minimum principal stress plots (left column Figure 8 - 
A,C,E) and the maximum principal stress plots (right column Figure 8-B,D,F) the most 
widespread stress levels (i.e. covering the greatest luminal area) in the lesion are determined 
and summarised in Table 3, in addition to the peak maximum principal stresses. This analysis 
is repeated for the other two elasticity models and the relevant values are also summarised in 
Table 3. Interestingly the compressive stresses appear dominant in the soft Ogden N1 model 
whereas in the stiffer P2 model the tensile stress appear more dominant. This highlights again 
the importance of appropriate mechanical characterisation of plaque tissue and its 
representation in silico. 
Discussion  
The main focus of this paper is to gain insight into the level of detail that is necessary and 
appropriate when modelling the response of atherosclerotic plaque tissue to stenting, and then 
to use these results to generate recommendations for the FDA for their guideline document 
for non-clinical engineering tests for coronary stents[38].  
The most significant conclusion to emerge from a detailed examination of the deformed 
lumen is that the choice of base atherosclerotic elasticity model is the overriding factor 
controlling lumen deformation. Secondly, the inclusion of the Mullins effect does not have 
significant effect on the deformed shape, whereas the inclusion of plasticity, as found in 
Conway et al.[1], does have a significant effect on the results for deformed lumen 
measurements. The inclusion of the Mullins effect does not limit the stress the tissue can 
support on loading, in contrast to perfect plasticity, which means that straining is encouraged 
when plasticity becomes active and this then affects the deformed lumen shape and size 
(Figure 5 and Figure 6). 
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Looking at the results locally, i.e. the deformations around the stent struts, one can see that 
the inclusion of a lipid pool with surrounding matrix of tissue modelled with Ogden N1 
induces a redistribution of lesion deformation along its length, and in particular generates a 
lower cross-sectional area around the struts post balloon deflation; on deflation, the lipid 
pool. However, when the surrounding matrix is modelled with the much stiffer Ogden N6 
model the local deformation distribution results are very similar, with and without a lipid 
pool. This is also the case for the P2 model. This indicates that presence of a lipid pool may 
only have an effect on a very soft surrounding matrix and less so on a stiff surrounding tissue.  
Looking at the inclusion of calcifications surrounded by a tissue matrix represented by the 
Ogden N1 model, a high variability in computed lumen deformation results is evident. The 
presence of the calcifications affects the local deformation both at inflation and on deflation. 
For the same given applied pressure to the balloon expanding the stent, the same deformed 
lumen is not achieved when calcifications are present. On deflation, the inclusion of 0.5% 
calcifications, by volume, reduces the range in lumen cross-sectional area by 0.2 mm
2
 or 3%. 
This implies that for even a small volume of calcifications present in a lesion (in this case 
0.5% of the total lesion volume) the cardiologist may have to inflate to a higher pressure to 
gain the desired lumen cross-sectional area. This is evident clinically also, as when 
calcifications are present sometimes a subsequent balloon inflation (with pressures up to 20 
atm) has been reported if adequate stent expansion is not achieved [53]. From a macroscopic 
perspective, the current study shows that stent expansion for a given balloon pressure is 
reduced when calcifications are present. The higher stiffness of plaque tissue when 
calcifications are present, as noted here, is consistent with experimental tissue testing 
observations [16,34]. 
From a percent tissue damage risk perspective for the non-diseased outer arterial layers, the 
inclusion of the Mullins effect on the base atherosclerotic tissue behaviour does not have a 
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significant effect, whereas the inclusion of plasticity has a relatively more significant effect. 
As a step toward representation of supra-physiological loading response the inclusion of 
plasticity could be recommended. As the inclusion of plasticity in the atherosclerotic tissue 
limits the stress supported by the tissue, it encourages redistribution of the stress in the non-
diseased arterial wall thus resulting in higher (and hence more conservative) predicted tissue 
damage risk. The results for the presence of a lipid pool indicate a somewhat softer overall 
atherosclerotic body in the simulations. Whereas the presence of diffuse calcifications 
increases the percent tissue damage risk in the Ogden N1 case modelled by 7%, which is 
consistent with calcifications increasing the plaque stiffness as noted above.  
In relation to the micromechanical stress state in the lesion itself, as summarised in Table 3, 
and focusing on the results for the most widespread minimum and maximum principal 
stresses, it can be seen for the (relatively soft) Ogden N1 material that the compressive 
minimum principal stress range is an order of magnitude greater than the tensile maximum 
principal stress range (0 – 1.9 MPa vs. 0 – 0.12 MPa), indicating a predominant (radial) 
compressive mode of loading. However, in contrast, for the significantly stiffer P2 material, 
the maximum tensile principal stress range is almost three times larger than the minimum 
compressive principal stress range (0 – 1.27 MPa vs. 0 – 0.5 MPa), indicating a predominant 
(circumferential) tensile mode of loading. This illustrates the importance of mechanically 
characterising atherosclerotic tissue in both tension and compression to fully capture the 
tissue behaviour, as this has important implications for the in silico deformation and stress 
state of the tissue during loading. These computed data allow for an assessment of plaque 
rupture risk. The availability of plaque mechanical properties, and in particular rupture 
properties, as discussed above, is limited; however a plaque rupture stress threshold of 300 
kPa, originally due to Cheng et al. [54], is widely quoted [14,16,33]. Cheng et al. [54] also 
reported an average rupture stress of 545 kPa ±160 kPa. From a consideration of the 
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published data to date, as recently reviewed [14,16,33,55], we believe that these values are 
quite reasonable for the purpose of making a basic assessment of the current model 
predictions. The stresses quoted above are Peak Circumferential Stresses (PCS), a measure 
that is commonly quoted in the literature when considering vulnerable plaque caps in 
particular [16,56]; this is a normal stress and in the context of the present model is arguably 
best compared with the predicted maximum principal stress [14]. Using the 300 kPa 
threshold, it is clear from Table 3 that for all but the first two cases with the softest base 
elasticity (OgN1, OgN1+lipid), the models predict that the expansion of this particular stent 
design could generate a plaque rupture risk.  
In addition to a principal stress-based assessment of plaque rupture risk, a limited von Mises 
stress based assessment is also possible, but based on even more limited rupture data. Using 
finite element models derived from MRI imaging of vulnerable plaques, Li et al. 
33
 reported a 
von Mises stress of 683.3 kPa for vulnerable plaques that had ruptured and a von Mises stress 
of 226.9 kPa for those that had not ruptured. Applying a critical von Mises stress of 683.3 
kPa to the present simulation results leads to essentially the same plaque rupture risk 
conclusions, as indicated for example by the extensive areas of high von Mises stress around 
the stent struts for the Ogden N1 with calcifications case relative to the Ogden N1 and Ogden 
N1 with lipid pool cases. Extensive areas of high von Mises stress (>683.3 kPa) are also 
observed for the remaining four cases considered above: OgN6, OgN6+lipid, P2, P2+lipid 
(results not shown).  
Consistent with the previous observations, the model predictions, in this case for the plaque 
rupture risk, are clearly strongly dependent on the choice of base atherosclerotic elasticity 
model, and also the choice of threshold stress, with the stiffer models indicating higher risk 
based on a single threshold stress, developing on the work of Timmins et al. [8] who carried 
out finite element analyses of stent deployment in the presence of plaques of varying 
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stiffness. Deformed radial position values were also plotted similar to the approach taken in 
Figure 5 presented in this work and the comparative qualitative behaviour is in agreement, in 
that the stiffer the base elasticity model, of the atherosclerotic tissue, the less expansion is 
observed. 
The strong influence of the calcified particles in increasing rupture risk is also clearly 
evident, as shown for the Ogden N1 case considered in this work. The calcifications clearly 
induce local stress concentrations in the plaque at the lumen surface. This is consistent with 
the computational modelling work of Maldonado et al. [56] and others [58–61], that has been 
focused on stress analysis of micro-calcifications in vulnerable plaque caps, and that indicate 
stress concentrations of up to 5 [56], or up to 16 [61] in the cap tissue local to clustered 
micro-calcifications. In relation to reported plaque rupture properties more generally, 
experimentally determined rupture properties are strongly tissue type specific, as recently 
reviewed as discussed above [16,17]; for example an average lipid dominant plaque rupture 
stress of 342 kPa and a calcified plaque rupture stress of 618 kPa are reported in [34]. 
The strong model sensitivities evident from the discussion this far clearly point towards the 
need for more detailed testing to generate accurate atherosclerotic tissue component-specific 
mechanical properties for both (i) constitutive behaviour to high strain and (ii) rupture, 
reflexive of supra-physiological loading experienced in stenting. Further, they substantiate 
the statements in Holzapfel et al. [14] on the need to identify and develop better failure 
criteria for plaque components, and the associated need for more experimental, analytical and 
numerical studies of plaque components [17].  The strong model sensitivities shown here also 
help address the question posed in Gijsen and Migliavacca [17] on whether multiscale plaque 
features need to be included in models for stress and strength analyses; our analyses suggest 
that multiscale plaque features should be included for accurate stress analyses. This is 
critically important in the further development of models for the test-bed, so that the lesion 
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rupture risk of different stent designs can be accurately assessed as part of the stent design 
process. 
Also to be considered are the limitations of this work. The assumption that the atherosclerotic 
tissue is isotropic, when in reality it is probably anisotropic due to the presence of collagen 
fibres, is a limitation. Another assumption, with regard to soft tissue, is material rate 
independence, although these tissues are most likely rate dependent and viscoelastic.  Again, 
adequate experimental data for this behaviour is currently lacking. A  third  assumption  is  
with  regard  to  the  representation  of  the  lipid  pool  as  a  soft solid  when  it  may  be  
more  appropriate  to  model  it  as  a  viscous  fluid. A further limitation is the morphology of 
the microcalcifications presented which are approximated as “brick-like” and dependent on 
element shape. The distribution of microcalcifications could also be increased and the 
particles allowed to coalesce as per a more advanced representation of the disease [62]. This 
could be developed for future applications of the test-bed approach presented here. Also not 
considered was axial pre-stretch or residual stress with in the vessel wall or the explicit 
representation of cardiac wall and surrounding tissues. The pressure due to pulsatile blood 
flow was not modelled as it was deemed that it was insignificant with respect to the force 
exerted by the stent implantation. However with regards the pressure change due to blood 
flow this may affect the damage accumulating due to stent implantation. This plaque damage 
modelling would require the use of more sophisticated and/or micromechanically based 
continuum damage approach – but such an in-depth focus was considered to be outside the 
scope of the present study.  
A final point on the approach taken in this work is that, similar to previous work [1], it is 
“population specific” and may create a working database or library to inform device 
designers as regards the range of patient responses to device implantation. This can 
complement the work performed in the patient specific modelling space also.   
22 
 
Conclusions and Recommendations 
Overviewing the results of the investigations (in terms of deformed lumen areas, predicted 
tissue damage risk and lesion microscale stress state) one is led to the central conclusion that, 
for stenting applications, the base elasticity model for the atherosclerotic tissue is the key 
aspect of the lesion modelling (for a given stenosis level) that determines the overall 
computational test-bed predictions; the choice of elasticity model dominates over the 
representation of plaque constituents and the inclusion of lesion tissue damage modelling 
(Mullins effect, plasticity).  
Having said this though, the plaque constituents and damage models are important, but to 
varying extents. As regards plaque constituents, the effects of calcifications are more 
significant than those of the lipid pool; even a small volume fraction of the former generates 
noticeable increases in lesion stiffness and stress levels, whereas a relatively large lipid pool 
induces only a modest softening overall with significant effects being observed only in the 
very soft base elasticity case (Ogden N1) at the level of local lesion deformation around the 
stent struts. As regards the lesion tissue damage modelling, plasticity is substantially more 
influential than the Mullins effect, in terms of inducing overall softening and stress 
redistribution in the tissue; in the context of the simulations considered here, the Mullins 
effect is not of primary importance. This may prove to be a useful result in guiding the 
identification and development of future failure criteria[14] and damage models for plaque 
components.  
In relation to the base elasticity of the atherosclerotic tissue, both the tensile and compressive 
behaviour are of critical importance. Additionally, an accurate knowledge of local lesion 
local rupture stress and strain would also guide the development of improved failure criteria 
[14]. This highlights the need for further careful mechanical characterisation of lesion tissue 
in terms of multi-mode mechanical testing up to rupture and the quantification of the local 
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rupture strain and stress state. In this context the test standard for uniaxial tensile testing of 
atherosclerotic tissue proposed in [33] is a useful development. However, given the complex 
deformation of plaque during stent deployment, the current study provides strong motivation 
for multi-axial mechanical testing, including biaxial and confined compression tests. 
Following the experimental approach used by Kelly and McGarry[63] for cancellous bone, 
confined compression should be performed in parallel with uniaxial tests to determine if 
plaque undergoes pressure dependent yielding. Based on previous finite element simulations 
using a crushable foam plasticity model it could be expected that the occurrence of pressure 
dependent yielding would further reduce the load bearing limit of the plaque, further 
increasing the stress in the arterial tissue during angioplasty [64].  
The current FDA guidelines for non-clinical engineering tests do not explicitly require the 
modelling of a lesion in their stress-strain analysis section in relation to stent deployment 
modelling. In Conway et al. [1], it was strongly recommended that for assessing device 
performance the presence of a lesion should be accounted for in computational models, and 
also that the quantity of lesion tissue should be varied. Building on these recommendations, 
from the results of this study the following is also recommended for stent deployment 
modelling in a virtual stenotic vessel: 
 The elastic behaviour of the atherosclerotic tissue represented in the models should 
cover a range of response types (stiff to compliant) due to the significant variation in 
experimentally determined tissue properties reported in the literature.  
 A comparison local (microscale) stress and strain with the local rupture state (rupture 
stress and strain) of the atherosclerotic tissue should be included in the modelling for 
meaningful device performance assessments to be made. This comparison should be 
tissue type specific (lipid plaque, calcified, etc.), due to the strong dependence of the 
local rupture state on atherosclerotic tissue type.  
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 Plaque constituents should be considered in atherosclerotic tissue models, such as 
calcifications and lipid regions, since in both cases their presence will influence the 
choice of atherosclerotic tissue rupture state for device performance assessment.  
 The incorporation of plasticity should be considered for the representation of 
atherosclerotic tissue damage in the models (due in part to its ease of 
implementation), in particular when assessing the effects of supra-physiological 
loading. 
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Table 1 Material parameters characterising the elastic constants for the stent 
deployment assembly. 
 E (MPa) υ (-) α (-) 
Balloon 850 0.4 8000 
Catheter 1000 0.4 8000 
Guidewire 62000 0.3 8000 
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Table 2  Values of  predicted percent tissue damage risk, as defined in Analysis of Results section,  in each arterial layer for the indicated 
atherosclerotic tissue models and inclusions. 
Homogenous Lesion 
 
Intima > 394kPa Media > 419kPa Adventitia 1300> kPa 
Model 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
P2 73.71 63.08 12.86 3.08 15.13 1.73 
P2 + Plasticity 70.26 62.25 6.88 1.67 9.82 1.02 
Ogden N1 44.78 34.25 0.81 0.13 0.25 0.06 
Ogden N1 + Mullins 43.78 31.29 0.79 0.12 0.23 0.03 
Ogden N6 54.17 44.00 1.92 0.63 1.65 0.34 
Ogden N6 + Mullins 57.13 44.96 2.05 0.62 1.90 0.32 
Lesion with Lipid Pool 
 
Intima > 394kPa Media > 419kPa Adventitia 1300> kPa 
Model 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
P2 71.53 61.52 11.13 2.79 12.29 1.49 
P2 + Plasticity 65.37 55.67 4.93 1.23 6.04 0.62 
Ogden N1 39.74 28.17 0.54 0.08 0.21 0.04 
Ogden N1 + Mullins 38.32 25.84 0.53 0.11 0.19 0.03 
Ogden N6 53.17 42.51 1.51 0.61 1.24 0.28 
Ogden N6 + Mullins 53.15 40.59 1.55 0.51 1.30 0.21 
Lesion with Calcifications 
 
Intima > 394kPa Media > 419kPa Adventitia 1300> kPa 
Model 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
Max 
Inflation 
Deflation 
Ogden N1 + Calc 41.90 36.45 5.81 4.19 0.00 0.00 
Ogden N1 + Mullins + Calc 41.10 35.15 5.75 4.09 0.00 0.00 
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Table 3  Most widespread maximum and minimum principal stress ranges (i.e. 
covering the greatest luminal area) in the lesion for different atherosclerotic 
tissue models at the point of maximum inflation. Peak maximum principal 
stress also shown.  
Model σmin range 
(MPa) 
σmax range 
(MPa) 
Peak σmax   
(MPa) 
Ogden N1 0 to -1.9 0 to 0.12 0.189 
OgdenN1 + lipid 0 to -1.9 0 to 0.12 0.189 
Ogden N1 + calc 0 to -1.9 0 to 0.12 10.0 
Ogden N6 0 to -0.47 0 to 0.45 3.4 
Ogden N6 + lipid 0 to -0.47 0 to 0.45 3.4 
P2 0 to -0.5 0 to 1.27 2.69 
P2 + lipid 0 to -0.5 0 to 1.27 2.69 
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Figure 1  Schematic of lipid pool with SAL50 arterial model, with insert showing mesh 
density. 
 
Figure 2 Schematic of calcified regions in SAL50 arterial model, with insert showing 
mesh density. 
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Figure 3  Uniaxial responses of material models for atherosclerotic tissue to monotonic 
loading in tension and compression. 
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Figure 4  A) Responses of Ogden models, with Mullins effect, to cyclic loading in 
tension and compression with softening on unloading illustrated. Response of 
Polynomial model to monotonic loading also shown. B) Cyclic strain loading 
amplitude.
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Figure 5  Cross-sectional measurements along the length of the atherosclerotic tissue geometry, Z position along axis (see Figure 1), at 
inflation and deflation timepoints. A) Ogden N6 with and without Mullins effect, B) Ogden N1 with and without Mullins effect, 
C) P2 with and without plasticity, D) Ogden N6 with lipid with and without Mullins effect, E) Ogden N1 with lipid with and 
without Mullins effect, F) P2 with lipid with and without plasticity, G) Ogden N1 with calcifications with and without Mullins 
effect.
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Figure 6 Results for percent change in average lumen cross-sectional area with 
respective to reference lumen area for all of the atherosclerotic tissue models 
discussed in text. Data was analysed at two time points, max balloon inflation 
(red “inflation” series) and post balloon deflation (blue “deflation” series). 
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Figure 7  Von Mises stress distribution (MPa) in atherosclerotic tissue, A) Max inflation for Ogden N1 material model, B) Deflation 
for Ogden N1 material model, C) Max inflation for Ogden N1 material model with lipid pool, D) Deflation for Ogden N1 
material model with lipid pool, E) Max inflation for Ogden N1 material model with calcifications and F) Deflation for 
Ogden N1 material model with calcifications. 
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Figure 8 Principal stress distribution (MPa) in atherosclerotic tissue at maximum balloon inflation, A) Minimum principal stress for 
Ogden N1 material model, B) Maximum principal stress for Ogden N1 material model, C) Minimum principal stress for 
Ogden N1 material model with lipid pool, D) Maximum principal stress for Ogden N1 material model with lipid pool, E) 
Minimum principal stress for Ogden N1 material model with calcifications and F) Maximum principal stress for Ogden 
N1 material model with calcifications. 
